Cite
HARVARD Citation
Wongchenko, M. et al. (n.d.). Exploratory biomarker analysis of first-line cobimetinib (C) + paclitaxel (P) in patients (pts) with advanced triple-negative breast cancer (TNBC) from the phase 2 COLET study. European journal of cancer. pp. S148-S149. [Online].